Literature DB >> 690319

Cardiovascular nuclear medicine and intensive care.

P J Ell, R M Donaldson.   

Abstract

The clinical application of cardiovascular nuclear imaging techniques to intensive care medicine holds great promise for improved non-invasive assessment of the patient. With the development of new radiopharmaceutical agents and better instrument resolution, it is now possible to provide quantitative information concerning myocardial perfusion, acute myocardial ischaemia, left ventricular function, thromboembolic pulmonary disease and analysis of the patient's respiratory function. The patient can be studied during various phases of his disease, with these techniques furnishing objective guidelines of the therapy and prognosis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 690319     DOI: 10.1007/BF01700251

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  20 in total

1.  Myocardial scintigraphy with technetrium-99m pyrophosphate during the early phase of acute infarction.

Authors:  B L Holman; M Lesch; J S Alpert
Journal:  Am J Cardiol       Date:  1978-01       Impact factor: 2.778

Review 2.  Echocardiography in pericardial effusion.

Authors:  A J Tjaik
Journal:  Am J Med       Date:  1977-07       Impact factor: 4.965

3.  Right ventricular infarction. Clinical and hemodynamic features.

Authors:  J N Cohn; N H Guiha; M I Broder; C J Limas
Journal:  Am J Cardiol       Date:  1974-02       Impact factor: 2.778

4.  A scintiphotographic method for measuring left ventricular ejection fraction in man without cardiac catheterization.

Authors:  H W Strauss; B L Zaret; P J Hurley; T K Natarajan; B Pitt
Journal:  Am J Cardiol       Date:  1971-11       Impact factor: 2.778

5.  The relative accuracy of echocardiography, intravenous CO2 studies, and blood-pool scanning in detecting pericardial effusions in dogs.

Authors:  E E Christensen; F J Bonte
Journal:  Radiology       Date:  1968-08       Impact factor: 11.105

6.  Factors influencing infarct size following experimental coronary artery occlusions.

Authors:  P R Maroko; J K Kjekshus; B E Sobel; T Watanabe; J W Covell; J Ross; E Braunwald
Journal:  Circulation       Date:  1971-01       Impact factor: 29.690

7.  Noninvasive quantitation of myocardial infarction with technetium 99m pyrophosphate.

Authors:  E H Botvinick; D Shames; H Lappin; J V Tyberg; R Townsend; W W Parmley
Journal:  Circulation       Date:  1975-11       Impact factor: 29.690

8.  Technetium stannous pyrophosphate myocardial scintigrams in the recognition of myocardial infarction in patients undergoing coronary artery revascularization.

Authors:  M R Platt; R W Parkey; J T Willerson; F J Bonte; W Shapiro; W L Sugg
Journal:  Ann Thorac Surg       Date:  1976-04       Impact factor: 4.330

9.  99mTc-imidodiphosphonate: a superior radio-pharmaceutical for in vivo positive myocardial infarct imaging. II: Clinical data.

Authors:  S P Joseph; P J Ell; P Ross; R Donaldson; A T Elliott; N J Brown; E S Williams
Journal:  Br Heart J       Date:  1978-03

Review 10.  Myocardial perfusion imaging and gated cardiac blood pool scanning: clinical application.

Authors:  B Pitt; H W Strauss
Journal:  Am J Cardiol       Date:  1976-11-23       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.